Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Immunocore Holdings
IPO Date: February 5, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $1.77B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.06 | 2.53%
Avg Daily Range (30 D): $0.59 | 1.72%
Avg Daily Range (90 D): $0.71 | 2.28%
Institutional Daily Volume
Avg Daily Volume: .26M
Avg Daily Volume (30 D): .32M
Avg Daily Volume (90 D): .33M
Trade Size
Avg Trade Size (Sh.): 73
Avg Trade Size (Sh.) (30 D): 63
Avg Trade Size (Sh.) (90 D): 71
Institutional Trades
Total Inst.Trades: 1,646
Avg Inst. Trade: $1.8M
Avg Inst. Trade (30 D): $1.5M
Avg Inst. Trade (90 D): $1.77M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $1.57M
Avg Closing Trade (30 D): $1.11M
Avg Closing Trade (90 D): $1.02M
Avg Closing Volume: 33.49K
   
News
Mar 10, 2025 @ 7:00 PM
Immunocore presents initial multiple ascending dos...
Source: N/A
Mar 6, 2025 @ 6:00 PM
TCR Therapy Clinical Trial Pipeline Accelerates as...
Source: Delveinsight
Jan 6, 2025 @ 12:00 PM
Immunocore to present at the 43rd Annual J.P. Morg...
Source: N/A
Jan 2, 2025 @ 12:00 PM
Immunocore appoints Travis Coy, previously a Non-E...
Source: N/A
Dec 23, 2024 @ 12:00 PM
Immunocore announces first patient dosed in the Ph...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.43 $.1 $-.47
Diluted EPS $-.43 $.1 $-.47
Revenue $ 333.58M $ 93.88M $ 84.05M
Gross Profit $ 330.27M $ 93.05M $ 83.72M
Net Income / Loss $ -21.63M $ 5.02M $ -23.77M
Operating Income / Loss $ -47.59M $ -3.62M $ -19.45M
Cost of Revenue $ 3.32M $ .83M $ .33M
Net Cash Flow $ -355.98M $ 21.11M $ -82.04M
PE Ratio